Focus on Renal Cell Carcinoma: Expert Insights and Strategies for Refining Patient Care

This comprehensive program gathers insight from 5 experts to discuss optimal management of patients with RCC featuring education on new agents and enhanced by practical tools for applying these findings in the clinic. All aspects of this program are designed to complement each other including an interactive treatment decision aid expert commentaries and an expert-authored module with downloadable slideset.

Share

Program Content

Activities

Downloadable Slideset
Focus on Renal Cell Carcinoma: Expert Insights and Strategies for Refining Patient Care
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: April 10, 2017

Expires: April 09, 2018

Activities

Cabozantinib in RCC
How Cabozantinib Is Transforming RCC Clinical Practice
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: December 19, 2016

Expires: December 18, 2017

Choosing Newer Agents in RCC
How I Choose Newer Agents for Patients With Advanced Renal Cell Carcinoma
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: February 27, 2017

Expires: February 26, 2018

TKIs in Era of Immunotherapy
Renal Cell Carcinoma in Transition: Role of TKI-Based Therapy in the Era of Immunotherapy
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: April 03, 2017

Expires: April 02, 2018

Faculty

cover img faculity

Neeraj Agarwal, MD

Professor of Medicine
Senior Director for Clinical Research, Huntsman Cancer Institute (HCI)
Presidential Endowed Chair of Cancer Research
Director, Center of Investigational Therapeutics
Director, Genitourinary Oncology Program
Huntsman Cancer Institute, University of Utah (NCI-CCC)
Salt Lake City, Utah

cover img faculity

Won Kim, MD

Assistant Clinical Professor of Medicine and Urology
Genitourinary Medical Oncology Program
University of California, San Francisco
San Francisco, California

cover img faculity

Robert Motzer, MD

Attending Physician
Memorial Sloan-Kettering Cancer Center
New York, New York

Provided by

ProCE Banner

Supporters

This activity is supported by educational grants from

Exelixis

Novartis Pharmaceuticals Corporation

Pfizer, Inc.